HHS launches public-private partnership to develop vaccines, therapies to treat coronavirus
April 17, 2020 / By Brooke Singman | Fox News
The Department of Health and Human Services on Friday announced plans to launch a new public-private partnership to develop a national strategy to create vaccines and therapies to treat the novel coronavirus.
On Friday, the National Institutes of Health and the Foundation for NIH announced the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) partnership.
More than a dozen biopharmaceutical companies, HHS’s Biomedical Advanced Research and Development Authority, the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration and the European Medicines Agency will partner to develop a strategy for a coordinated research response to the COVID-19 pandemic.
“The ACTIVE partnership will bring new levels of coordination and speed to public and private work on therapies and vaccines for COVID-19—work that NIH, HHS, and the Trump administration began literally days after the coronavirus threat was identified in China in January,” HHS Secretary Alex Azar said in a statement Friday.
